Literature DB >> 9786572

Evaluation of a new staging system by the Japanese Research Society for Gastric Cancer.

T Ochiai1, H Hayashi, T Suzuki, K Nakajima, H Shimada, E Hishikawa, A Yasumoto, A Takeda, K Isono.   

Abstract

The feasibility of the new classification of stage grouping by the Japanese Research Society for Gastric Cancer was evaluated. During the 22-year period between January 1975 and December 1996, a total of 1294 patients with primary gastric cancer underwent laparotomy at the Department of Surgery, Chiba University; 1222 had their lesions removed during the gastrectomy and 72 remained nonresected. Cases of direct operative death totaled 17 (1.3%). Five hundred patients (38.6%) died of a relapse of the original cancer and 42 (3.2%) died of other diseases within the followup period. Six patients (0.5%) were lost during the followup. The 5-year cumulative patient survival rates of the seven stages of the new stage grouping were distinctly proportional, and the differences were also statistically significant except between stages IIIb and IVa. The two major revised points in the new stage grouping, new classification of the depth of cancer invasion, and new stage grouping by a mosaic combination of the degree of invasion and lymph node metastasis were thus found to be reasonable based on the actuarial 5-year survival rates of the subgroups in the same stage. The present study also showed that the classification of stage IV still requires further discussion.

Entities:  

Mesh:

Year:  1998        PMID: 9786572     DOI: 10.1007/BF02483954

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  6 in total

1.  Evaluation of the TNM classification of stomach cancer and proposal for its rational stage-grouping.

Authors:  K Miwa
Journal:  Jpn J Clin Oncol       Date:  1984-09       Impact factor: 3.019

2.  The general rules for the gastric cancer study in surgery and pathology. Part I. Clinical classification.

Authors:  T Kajitani
Journal:  Jpn J Surg       Date:  1981-03

3.  The general rules for the gastric cancer study in surgery ad pathology. Part II. Histological classification of gastric cancer.

Authors: 
Journal:  Jpn J Surg       Date:  1981-03

4.  Prognostic significance of the number of positive lymph nodes in gastric carcinoma.

Authors:  Y Adachi; T Kamakura; M Mori; H Baba; Y Maehara; K Sugimachi
Journal:  Br J Surg       Date:  1994-03       Impact factor: 6.939

5.  Comparison of the prognostic significance between the number of metastatic lymph nodes and nodal stage based on their location in patients with gastric cancer.

Authors:  T Ichikura; S Tomimatsu; Y Okusa; K Uefuji; S Tamakuma
Journal:  J Clin Oncol       Date:  1993-10       Impact factor: 44.544

6.  Postoperative staging of gastric carcinoma. A comparison between the UICC stage classification and the 12th edition of the Japanese General Rules for Gastric Cancer Study.

Authors:  Y Kodera; Y Yamamura; A Torii; K Uesaka; T Hirai; K Yasui; T Morimoto; T Kato; T Kito
Journal:  Scand J Gastroenterol       Date:  1996-05       Impact factor: 2.423

  6 in total
  3 in total

1.  Alterations of tumor-related genes do not exactly match the histopathological grade in gastric adenocarcinomas.

Authors:  Guo-Yan Liu; Kun-Hong Liu; Yong Zhang; Yu-Zhi Wang; Xiao-Hong Wu; Yi-Zhuo Lu; Chao Pan; Ping Yin; Hong-Feng Liao; Ji-Qin Su; Qing Ge; Qi Luo; Bin Xiong
Journal:  World J Gastroenterol       Date:  2010-03-07       Impact factor: 5.742

2.  The pattern of lymph node metastasis and the suitability of 7th UICC N stage in predicting prognosis of remnant gastric cancer.

Authors:  Fangxuan Li; Rupeng Zhang; Han Liang; Hui Liu; Jichuan Quan; Jingzhu Zhao
Journal:  J Cancer Res Clin Oncol       Date:  2011-11-03       Impact factor: 4.553

3.  Prognostic value of autophagy related proteins ULK1, Beclin 1, ATG3, ATG5, ATG7, ATG9, ATG10, ATG12, LC3B and p62/SQSTM1 in gastric cancer.

Authors:  Qing-Hua Cao; Fang Liu; Zu-Li Yang; Xin-Hui Fu; Zi-Huan Yang; Quentin Liu; Lei Wang; Xiang-Bo Wan; Xin-Juan Fan
Journal:  Am J Transl Res       Date:  2016-09-15       Impact factor: 4.060

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.